Clinical Characteristics of Patients With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
-
median age was 9 years (IQR, 5.7-14; range, 3 months-17 years)
-
33 were girls (57%)
-
40 (69%) were of black or Asian race
-
only 7 had comorbidities, including 3 with asthma, 1 with neurodisability, 1 with epilepsy, 1 with sickle cell trait, and 1 with alopecia
-
100% of patients presented with persistent fever for 3 to 19 days and variable combinations of s
-
sore throat (n = 6 [10%])
-
headache (n = 15 [26%])
-
abdominal pain (n = 31 [53%])
-
erythematous rashes were present in 30 (52%)
-
conjunctival injection was noted in 26 (45%)
-
lymphadenopathy in 9 (16%)
-
mucus membrane changes and red cracked lips in 17 (29%)
-
swollen hands and feet in 9 (16%).
Admission to pediatric critical care units was required in 29 patients (50%) and 13 (22%) developed acute kidney injury. Shock requiring inotropic support was present in 27 patients (47%). Mechanical ventilation was used for respiratory support in 25 patients (43%)
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Case Definition for Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Clinical Characteristics of Patients With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
SARS-CoV-2 Test Results for 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Comparison of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Other Childhood Inflammatory Diseases